Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Budde

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2011
How to use mTOR inhibitors? The search goes onK Budde
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 9, 2007
Lessons from the CAESAR Study: calcineurin inhibitors--can't live with them and can't live without themB Kaplan, K Budde
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 24, 2014
Bortezomib-based antibody reduction therapy: the first step to “true” desensitization?K Budde, L J Lehner
Pediatric Nephrology (Berlin, Germany)|September 3, 2016
Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patientsS Brakemeier, F Bachmann, K Budde
Vaccine|November 19, 1997
OPV vs IPV--could placental immunity reduce the number of vaccine-associated paralytic poliomyelitis?R Fescharek, R K Budde, C Arras
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
The diagnostic value of GM-CSF and IL-6 determinations in patients after renal transplantationK Budde, J Waiser, H H Neumayer
Lancet (London, England)|February 1, 1997
Differing proteinuria control with cyclosporin and tacrolimusK Budde, L Fritsche, H H Neumayer
Deutsche Medizinische Wochenschrift (1946)|April 18, 2003
[Treatment of hypercholesterolemia in kidney transplant recipients]L Fritsche, K Budde, H-H Neumayer
Clinical Pharmacology and Therapeutics|July 1, 2011
Biomarkers of over-immunosuppressionK Budde, M Matz, M Dürr, et al.
Transplantation Proceedings|December 5, 2017
Long-Term Outcomes of Kidney Transplant Recipients With Primary Idiopathic Focal Segmental GlomerulosclerosisO Staeck, F Halleck, K Budde, et al.
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 15, 2011
How to use mTOR inhibitors? The search goes onK Budde
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 9, 2007
Lessons from the CAESAR Study: calcineurin inhibitors--can't live with them and can't live without themB Kaplan, K Budde
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 24, 2014
Bortezomib-based antibody reduction therapy: the first step to “true” desensitization?K Budde, L J Lehner
Pediatric Nephrology (Berlin, Germany)|September 3, 2016
Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patientsS Brakemeier, F Bachmann, K Budde
Vaccine|November 19, 1997
OPV vs IPV--could placental immunity reduce the number of vaccine-associated paralytic poliomyelitis?R Fescharek, R K Budde, C Arras
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
The diagnostic value of GM-CSF and IL-6 determinations in patients after renal transplantationK Budde, J Waiser, H H Neumayer
Lancet (London, England)|February 1, 1997
Differing proteinuria control with cyclosporin and tacrolimusK Budde, L Fritsche, H H Neumayer
Deutsche Medizinische Wochenschrift (1946)|April 18, 2003
[Treatment of hypercholesterolemia in kidney transplant recipients]L Fritsche, K Budde, H-H Neumayer
Clinical Pharmacology and Therapeutics|July 1, 2011
Biomarkers of over-immunosuppressionK Budde, M Matz, M Dürr, et al.
Transplantation Proceedings|December 5, 2017
Long-Term Outcomes of Kidney Transplant Recipients With Primary Idiopathic Focal Segmental GlomerulosclerosisO Staeck, F Halleck, K Budde, et al.
Pageof 16